Bayer's Vitrakvi On Track To Become EU’s First Tumor-Agnostic Cancer Treatment

 
• By Vibha Sharma
Larotrectinib
Vitrakvi Is First Tumor-Agnostic Treatment Recommended For Pan-EU Approval • Source: Shutterstock

More from Europe

More from Geography